Careland Kinesiology Dual Action Pain Relieving Tape
NDC 75568-050
Product Information
Careland Kinesiology Dual Action Pain Relieving Tape (lidocaine) is a OTC MONOGRAPH DRUG-approved product labeled by Planet (anhui) Pharmaceutical Co., Ltd.. This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It is supplied as a tape for topical administration. This product entry covers the primary NDC 75568-050 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 75568-050?
What are the uses of this product?
What are Active Ingredients of this product?
- LIDOCAINE 40 mg/g - A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
- MENTHOL, UNSPECIFIED FORM 10 mg/g
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LIDOCAINE (UNII: 98PI200987)
- LIDOCAINE (UNII: 98PI200987) (Active Moiety)
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)
- MENTHOL (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALUMINUM SILICATE (UNII: T1FAD4SS2M)
- MINERAL OIL (UNII: T5L8T28FGP)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER (UNII: K7S96QM8DV)
- TERPENE RESIN (UNII: GR35AH6YDN)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.